Cargando…
587. Risk Factors for Nosocomial Methicillin-Resistant Staphylococcus aureus (MRSA) Colonization in a Neonatal Intensive Care Unit (NICU): A Case–Control Study
BACKGROUND: Staphylococcus aureus (SA) is a leading cause of nosocomial infection in NICUs. Colonization is a prerequisite for most SA infections. Previously recognized risk factors for colonization include the length of stay (LOS), multiple gestation, low birth weight, Caesarean delivery and multib...
Autores principales: | Balamohan, Archana, Beachy, Joanna, Kohn, Nina, Rubin, Lorry G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810579/ http://dx.doi.org/10.1093/ofid/ofz360.656 |
Ejemplares similares
-
2304. Decreased Incidence of Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections after Implementation of Routine Surveillance and Decolonization in a Level IV Neonatal Intensive Care Unit (NICU)
por: Balamohan, Archana, et al.
Publicado: (2018) -
Lower Methicillin-Resistant Staphylococcus aureus (MRSA) Acquisition and Nosocomial Cultures While on Anti-MRSA Antibiotics?
por: Jones, Makoto, et al.
Publicado: (2015) -
P050: Containment of methicillin resistant staphylococcus aureus (MRSA) outbreak in a neonatal intensive care unit (NICU)
por: Eluk, O, et al.
Publicado: (2013) -
Telavancin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA)
por: Hooper, Candace Y, et al.
Publicado: (2012) -
Nosocomial methicillin-resistant staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy
por: Pletz, Mathias W, et al.
Publicado: (2010)